Compare Marathon Digital Holdings Inc (MARA) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Digital Holdings Inc vs TransMedics Group Inc — how do they compare? Marathon Digital Holdings Inc trades at $9.55 (market cap $3.83B), while TransMedics Group Inc trades at $78.41 (market cap $2.74B). The key difference: Marathon Digital Holdings Inc is the larger of the two by market cap, and TransMedics Group Inc is more actively traded (949,331 versus 47,742,698). Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and TransMedics Group Inc for 24 Days on average.
| MARA | TMDX | |
|---|---|---|
Market Cap | $3.83B | $2.74B |
Volume | 47,742,698 | 949,331 |
Sector | Financials | Health |
52-Week High | $22.84 | $150.42 |
52-Week Low | $6.73 | $61.99 |
Typical Hold Time | 22 Days | 24 Days |
Enterprise Value | $5.87B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Digital Holdings (MARA) trades at $9.60, down 7.34% on the day, reflecting ongoing volatility. The stock shows mixed signals with bearish technical indicators but positive analyst sentiment. Fundamentally, the company reported significant losses with a net income margin of -429.71% in 2026, though revenue remains substantial at $804 million. Recent news highlights stock movements tied to Bitcoin price fluctuations and analyst coverage, including a Hold rating from Clear Street with a $10 price target.
The outlook remains cautious due to persistent losses and high volatility, though analyst consensus suggests potential upside to $13.25. Key risks include operational cash burn, competitive pressures, and regulatory uncertainty. Investment opportunity exists if the company can improve profitability and manage costs effectively, but current financial health warrants careful monitoring.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
